UltraPlasma™ Tinea Versicolor Treatment

withOut! Drugs, Industrial Chemicals, Medicines, Surgery, Supplements, and Lasers. | ! not to be confused with pityriasis rosea versicolor or rosacea.

TREATMENTS

MedicaLabs, Germany | https://medicalabs.de

10/24/20243 min read

ultraplasma.com_Tinea_Versicolor_treatment_tinea_mantar_tedavi_ultrap_plasma_ultra_plazma
ultraplasma.com_Tinea_Versicolor_treatment_tinea_mantar_tedavi_ultrap_plasma_ultra_plazma
ultraplasma.com_Tinea_Versicolor_treatment_tinea_mantar_tedavi_ultrap_plasma_ultra_plazma
ultraplasma.com_Tinea_Versicolor_treatment_tinea_mantar_tedavi_ultrap_plasma_ultra_plazma
ultraplasma.com Tinea Versicolor woodlamp diagnosis
ultraplasma.com Tinea Versicolor woodlamp diagnosis

Tinea versicolor Diagnosis with wood-lamp

UltraPlasma™

ultraplasma.com

UltraPlasma™ Multi-Platform Plasma Systems in the Treatment of Tinea Versicolor

Introduction

Tinea versicolor, also known as pityriasis versicolor, is a common superficial fungal infection caused by Malassezia species. Characterized by hypo- or hyperpigmented patches, it often affects the trunk, neck, and upper arms. Traditional antifungal treatments sometimes yield inconsistent outcomes due to fungal resistance or poor skin penetration. The UltraPlasma™ multi-platform plasma system introduces an innovative, non-invasive approach utilizing arc, argon, and helium plasmas, in combination with a smart spectrum-modulating software-hardware architecture, to treat Tinea versicolor efficiently.

1. UltraPlasma™ Technology and the Skin

The UltraPlasma™ device operates through controlled emission of:

  • Arc Plasma (White-Blue Spectrum): High-intensity localized discharges used for surface disinfection and fungal breakdown.

  • Argon Plasma (Blue-Violet Spectrum): Medium-depth ionization with strong bacteriostatic and fungistatic effects.

  • Helium Plasma (Violet Spectrum): Soft, deep-reaching energy transfer used to stimulate dermal blood flow and immune response.

These plasma sources generate reactive species such as:

  • Ozone (O₃)

  • Nitric Oxide (NO)

  • Reactive Oxygen Species (ROS)

  • Reactive Nitrogen Species (RNS)

These reactive agents collectively inactivate fungal colonies and normalize skin microflora.

2. Epidermis, Dermis, Hypodermis: Role in Treatment

Epidermis (Surface Action)

  • Disruption of fungal cell walls via oxidative stress

  • Ozone and ROS act on keratinocytes and fungal spores

  • Plasma-induced exfoliation removes infected stratum corneum

Dermis (Vascular & Immune Stimulation)

  • NO improves microcirculation, promoting local immunity

  • Helium plasma energizes fibroblasts, enhancing tissue repair

  • Argon plasma promotes cytokine modulation to reduce inflammation

Hypodermis (Systemic Support)

  • Deep helium plasma penetrates fatty tissues where Malassezia may persist

  • Activation of lipid-associated immune mediators

  • Indirect systemic immunostimulation via plasma-transdermal influence

3. Gas Dynamics and Emission Control

UltraPlasma™’s proprietary adaptive modulation interface allows:

  • Custom tuning of gas ratios (O₂, He, Ar)

  • Real-time control of voltage, frequency, and pulse width

  • Specific emission targeting via smart waveform shaping

The result is precision-matched plasma outputs for different stages of fungal activity and skin regeneration.

4. Clinical Protocol Suggestion

5. Advantages Over Traditional Therapies

6. UltraPlasma™ vs Traditional Antifungal Therapies

⌘Conclusion⌘

The UltraPlasma™ system presents a revolutionary, non-invasive approach to treating Tinea versicolor by integrating arc, argon, and helium plasma technologies. These plasma types, carefully modulated via a unique software and hardware interface, enable:

  • Precise emission control

  • Layer-specific penetration

  • Customized gas outputs (O₃, NO, ROS, RNS)

Through these mechanisms, UltraPlasma™ achieves:

  • Rapid fungal inactivation

  • Restoration of skin barrier

  • Improved microcirculation and immune modulation

  • Long-term relapse prevention

By addressing not only the surface infection but also the vascular and immune factors in deeper skin layers, UltraPlasma™ surpasses conventional topical and systemic therapies.

Shortcut for our Goals!